Marketing-authorisation holder

Cutter Med & Biol, Division of Miles Canada Ltd.

12 medicines1 country

12 medicines in 1 country, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

12 medicines

Medicine	Substance	Country	Status	Authorised
ANTICOAGULANT CITRATE DEXTR SOL FORMULA A USP730 mg / 100 ml + 2.45 g / 100 ml + 2.2 g / 100 ml · Liquid	Citric acid, Dextrose, Sodium citrate	Canada	Cancelled	1988
ANTICOAGULANT SODIUM CITRATE SOL 4% USP4 % / % · Liquid	Sodium citrate	Canada	Cancelled	1988
GAMASTAN16.5 % · Liquid	Immunoglobulin	Canada	Cancelled	1951
GAMIMUNE N INJ 5% (IV)50 mg / ml · Liquid	Immunoglobulin	Canada	Cancelled	1986
HEPATITIS B IG INJLiquid	Hepatitis b immunoglobulin	Canada	Cancelled	1982
HYP RHO D INJ 16.5%16.5 % / % · Liquid	Anti-d (rh) immunoglobulin	Canada	Cancelled	1979
HYPER TET16.5 % / % · Liquid	Tetanus immunoglobulin	Canada	Cancelled	1959
HYPERAB RABIES IMMUNE GLOBULIN HUMAN16.5 % / % · Liquid	Rabies immunoglobulin	Canada	Cancelled	1985
HYPERHEP INJLiquid	Hepatitis b immunoglobulin	Canada	Cancelled	1981
NORMAL SERUM ALBUMIN HUMAN 25% USP25 % / % · Liquid	Albumin	Canada	Cancelled	1951
PLASBUMIN-5 INJ 50MG/ML50 mg / ml · Liquid	Albumin	Canada	Cancelled	1985
PLASMANATE INJ 0.05GM/ML USP88 % / % + 7 % / % + 5 % / % · Liquid	Albumin, Alpha-globulin, Beta globulin	Canada	Cancelled	1985

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Marketing-authorisation holder

12 medicines1 country

12 medicines in 1 country, as authorisation holder.

Every medicine in the registers under its name, current ones first.

12 medicines

Medicine	Substance	Country	Status	Authorised
ANTICOAGULANT CITRATE DEXTR SOL FORMULA A USP730 mg / 100 ml + 2.45 g / 100 ml + 2.2 g / 100 ml · Liquid	Citric acid, Dextrose, Sodium citrate	Canada	Cancelled	1988
ANTICOAGULANT SODIUM CITRATE SOL 4% USP4 % / % · Liquid	Sodium citrate	Canada	Cancelled	1988
GAMASTAN16.5 % · Liquid	Immunoglobulin	Canada	Cancelled	1951
GAMIMUNE N INJ 5% (IV)50 mg / ml · Liquid	Immunoglobulin	Canada	Cancelled	1986
HEPATITIS B IG INJLiquid	Hepatitis b immunoglobulin	Canada	Cancelled	1982
HYP RHO D INJ 16.5%16.5 % / % · Liquid	Anti-d (rh) immunoglobulin	Canada	Cancelled	1979
HYPER TET16.5 % / % · Liquid	Tetanus immunoglobulin	Canada	Cancelled	1959
HYPERAB RABIES IMMUNE GLOBULIN HUMAN16.5 % / % · Liquid	Rabies immunoglobulin	Canada	Cancelled	1985
HYPERHEP INJLiquid	Hepatitis b immunoglobulin	Canada	Cancelled	1981
NORMAL SERUM ALBUMIN HUMAN 25% USP25 % / % · Liquid	Albumin	Canada	Cancelled	1951
PLASBUMIN-5 INJ 50MG/ML50 mg / ml · Liquid	Albumin	Canada	Cancelled	1985
PLASMANATE INJ 0.05GM/ML USP88 % / % + 7 % / % + 5 % / % · Liquid	Albumin, Alpha-globulin, Beta globulin	Canada	Cancelled	1985

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Canada	12	0	12	Companies All medicines

The ATC groups most of its medicines belong to, largest first.

Immune sera and immunoglobulinsAnti-infectives for systemic use · ATC J06B
Blood substitutes and perfusion solutionsBlood and blood-forming organs · ATC B05A
All other non-therapeutic productsVarious · ATC V07A

The active substances in most of its medicines.

How the registers spell it, normalised: legal forms, accents and capitals removed.

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Report an error or request removalCorrections from the company itself are welcome.